% | $
Quotes you view appear here for quick access.

Dynavax Technologies Corporation Message Board

  • rebusoeconomicisminister rebusoeconomicisminister Jul 10, 2013 9:33 AM Flag

    GREAT presentation

    Waiting for the webcast replay to post so I can hear the 12:15-ish comments from Ostrach. When asked about the trial size and cost, he replied in summary: "We will explore all options for the capitalization of Heplisav" -- Does that mean a partner? Sale?

    The trial requirement comments were phenomenal! Small study, short time frame... go go go!

    EU on track!

    If you did not hear the presentation, get on over to the Dynavax website and hit PLAY, when it posts!

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
15.850.00(0.00%)May 27 4:00 PMEDT